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Introduction: Anxiety and depressive disorders are a significant problem that starts
in childhood or adolescence and should be addressed early to avoid chronic mental
conditions. There is strong evidence to demonstrate that psychological treatments are
effective for these disorders, however, little is known on mediators and mechanisms of
change of psychological treatment in adolescents and young adults. Understanding
the pathways through which psychological treatments operate will facilitate more
effective treatments.
Aim: We aim to conduct a systematic review, exploring the available evidence on
mediators of psychological treatments for anxiety and depression in adolescents
and young adults.
Methods: A systematic search has been performed on PubMed and PsycINFO
databases to identify studies from inception to 23rd February 2020. Eligible studies
include randomized controlled trials and trials (quasi-experimental) designs that have
enrolled adolescents and young adults presenting with depression and/or anxiety and
that have examined mediators of psychological treatments. A group of 20 reviewers
from the COST-Action TREATme (CA16102) divided into 10 pairs independently screen
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studies for inclusion, extract information from the included studies, and assess the
methodological quality of the included studies and the requirements for mediators.
The methodological quality will be assessed by The Mixed Methods Appraisal Tool.
Extracted data from the included studies will be collected and presented using a
narrative approach.
Discussion: This systematic review will summarize and provide a comprehensive
overview of the current evidence on mediators of psychological treatments for anxiety
and depression for adolescents and young adults. Results will allow the identification of
strategies to optimize intervention to enhance clinical outcomes.
Ethics and dissemination: Ethics approval is not required. Findings from this
systematic review will be published in a peer-reviewed journal and disseminated at
conferences and meetings. PROSPERO registration number: CRD42021234641.
Keywords: systematic review, anxiety, depression, young adult, adolescence, mediator, psychotherapy
INTRODUCTION
Anxiety and depressive disorders are a significant public
health concern. According to the World Health Organization
(WHO), approximately 264 and 322 million people suffer
from anxiety and depressive disorders, respectively (World
Health Organization, 2017). Comorbidity between anxiety and
depressive disorders is highly common and the risk of one
disorder can increase the risk of another (Kessler et al., 2011;
Cummings et al., 2014). In terms of disease burden, anxiety
and depressive disorders are among the leading causes of
years lived with disability for all ages (GBD, 2020). Both
disorders are associated with high economic costs (Olesen
et al., 2012) and depression is associated with high mortality
(Cuijpers et al., 2014).
Adolescents and young adults are a fundamental and
vulnerable group with distinct mental health needs. Anxiety
disorders typically begin in childhood, the median age of onset
being 11 years, whereas depression frequently manifests later
during adolescence or early adulthood, and its mean age of
onset has been estimated around 30 years (Kessler et al., 2005).
At a global level, in 2019, anxiety and depressive disorders
have been the sixth and the fourth leading cause of illness
and disability among adolescents and young adults aged 10–
24 years, respectively (GBD, 2020). The consequences of not
addressing these emotional disorders during this period leads
to considerable suffering and impaired functioning, affecting
physical and mental health and limiting opportunities to lead
fulfilling lives as adults limiting opportunities extend into
adulthood (World Health Organization, 2020).
There is strong evidence on the effectiveness of psychological
treatments for anxiety disorders (Zhou et al., 2019) and
depression (Zhou et al., 2015) in children and adolescents.
Cognitive-behavioral therapy (CBT) is the most researched
and commonly used psychological treatment for anxiety and
depressive disorders in children and adolescents (David-Ferdon
and Kaslow, 2008; Silverman et al., 2008; Weersing et al., 2017).
Interpersonal psychotherapy (IPT) is also considered evidence-
based psychotherapy for youth depression (Birmaher et al., 2007;
National Institute for Clinical Excellence, 2015; Zhou et al.,
2015). IPT is less studied than CBT but shows promising results
for anxiety disorders (although with no superiority compared
to other bona fide therapies) (Markowitz et al., 2014). Other
treatment approaches such as psychodynamic psychotherapy,
acceptance and commitment therapy, or mindfulness have also
been used for anxiety and depressive disorders (Abbass et al.,
2013; Chi et al., 2018; González-Valero et al., 2019; Harris and
Samuel, 2020; Midgley et al., 2021).
However, the treatment effect sizes have substantial room for
improvement. A meta-analysis of the youth therapy evidence
base conducted by Weisz et al. (2017) found a medium effect
size for treating anxiety when they compared active treatments
vs. control condition. In depression, the differences between-
group treatment effects were smaller, showing small to medium
effect sizes (Weisz et al., 2017; Eckshtain et al., 2020). IPT has
shown greater effect sizes than other psychological treatments
for depression in the treatment of adolescents, although the
number of RCTs that evaluated the effectiveness of IPT was much
more limited (Eckshtain et al., 2020). In the case of anxiety, the
evidence for the effectiveness of IPT is very scarce (Markowitz
et al., 2014). González-Valero et al. (2019) performed a meta-
analysis of the effects of mindfulness-based approaches, self-
reflection and cognitive behavioral therapy in youth showing
satisfactory and significant results in relation to the reduction of
anxiety and depression in youth. Another meta-analysis focused
exclusively on mindfulness had moderate effects in reducing
depression in young people at post-test (Chi et al., 2018).
Regarding psychodynamic therapy, the evidence suggests this
approach may be especially effective for treating anxiety and
depression in children and adolescents (Abbass et al., 2013;
Midgley et al., 2021). In order to optimize treatments, one of
the main challenges for psychotherapy research is to identify
the mechanisms and therapeutic processes that lead to positive
outcomes and improvements over the course of psychological
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treatments. Mechanisms of change define causal relationships
between psychological treatments and therapeutic change.
A mechanism of change explains how a treatment translates into
a process that leads to an outcome (Kazdin, 2007). Understanding
the mechanisms through which psychological treatments operate
will likely facilitate the development of new treatments with
better outcomes and, possibly, greater cost-effectiveness. In this
way, the active therapeutic components could be intensified
and refined, while the inactive or redundant elements could be
discarded (Kazdin and Weisz, 1998; Kraemer et al., 2002).
An important first step toward examining mechanisms of
change in psychological treatments is the identification of
mediators of outcome (Kraemer et al., 2002; Kazdin and Nock,
2003). A mediator is a construct that shows statistical relations
between treatment and outcome but may not explain the precise
process through which change comes about (Kazdin, 2007).
Kazdin’s (2007) recommendations to better understand the
mediators and mechanisms of therapy are the following: (1) use
theory of psychological change as a guide, (2) include measures
of potential mediators in treatment studies, (3) establish the
timeline of the proposed mediator or mechanism and outcome,
(4) assess more than one mediator or mechanism, (5) use designs
that can evaluate mediators and mechanisms (randomized
controlled trials -RCTs- are excellent designs in demonstrating
a causal relationship between the treatment and therapeutic
change), (6) examine consistencies across different types of
studies, and (7) intervene to change the proposed mediator or
mechanism. Despite the recommendations on how to evaluate
the mediators and mechanisms of change in psychological
treatments, little progress has been made in the research on
mechanisms of change in the treatment of adolescents and
young adults (Kazdin and Nock, 2003). Cuijpers et al. (2019)
concluded that we have no empirically validated mechanisms of
change in adult psychotherapy after several decades of systematic
psychotherapy research.
Some efforts have been made to identify mediators of
psychological treatments in the treatment of young adults with
depression. The reviews on this topic have focused mainly
on CBT and, to a lesser extent, on IPT. Weersing and
Weisz (2002) conducted a systematic review which included
RCTs targeting various youth problems. For depression, they
identified 12 RCTs that assessed some candidate mediators
(cognitive distortions, self-concept, social adjustment, pleasant
activities, among others). Although some included studies found
that psychological treatments changed the candidate mediator
compared to control groups, most of the studies did not
conduct a formal mediation test. The meta-analysis of Chu
and Harrison (2007) included 14 RCTs on the effectiveness of
CBT in depressive outcomes, but only three RCTs examined
treatment mediators. This meta-analysis found that CBT had
significant small-to-medium effects on cognitive candidate
mechanisms and no significant effects on behavioral and coping
mechanisms. After nearly a decade from Chu and Harrison’s
review, Weersing et al. (2017) carried out a systematic review
that included only RCTs where different candidate mediators
of interventions for the treatment of young adult depression
were tested. The mediators identified by the authors for CBT
were cognitive, behavioral and motivational. However, these
findings were based on only five RCTs and some failed to
meet the basic requirements for identifying mediators, such
as to establish temporal precedence of change. In another
systematic review conducted by Lemmens et al. (2016) on
mechanisms of change in psychotherapy for depression, some
mediators such as rumination and worries were identified. They
concluded that research is heterogeneous and unsatisfactory
in many methodological respects, but also that psychotherapy
might be too complex to be explained in simple models of
psychological change. In their systematic review, the authors
only included nine studies for the treatment of adolescents with
depression. Recently, Ng et al. (2020) conducted a systematic
review and selected 46 randomized trials of CBT and IPT
with depressed youths; 74% measured candidate mediators,
but only 17% analyzed these factors as mediators. Although
four significant candidate mediators (negative cognition, family
functioning, treatment expectancy, and motivation to change)
emerged, findings were sparse, conflicting, and clouded by
methodological issues. These studies highlight that only a
minority of RCTs tested candidate mechanisms as mediators, and
the vast majority assessed CBT.
For the treatment of anxiety, the evidence is even more
limited. The systematic reviews that have been performed have
focused on specific mediators or treatments and were not
based on the young population. Smits et al. (2012) reviewed
the evidence for the threat reappraisal mediation hypothesis
for CBT treatment of anxiety disorders. Most of the studies
identified included samples of adults who have panic disorder
or social anxiety disorder. Therefore, it was not possible to
examine whether threat reappraisal mediation of CBT efficacy
varied across the anxiety disorders. The authors concluded that
threat reappraisal is related to anxiety symptom improvement
with CBT. However, they could not demonstrate that threat
reappraisal causes symptom improvement in CBT. Moreover,
they could not demonstrate that threat reappraisal is not a
substitute for other third variables, since few studies meet
most of the criteria necessary to establish causality. Another
systematic review carried out by Gregory and Peters (2017)
showed that change in self-related constructs (self-esteem, self-
schema, self-focused attention, and self-evaluation) predicted
and/or mediated social anxiety reduction. However, the studies
were very few and had methodological limitations. On the
other hand, Fentz et al. (2014) studied the mediational role of
panic self-efficacy in CBT for panic disorder. Results provided
some support for panic self-efficacy as a mediator of treatment
outcome, although none of the studies met all of the criteria
proposed by the authors for establishing mediation. In their
meta-analysis on the effectiveness of CBT in anxiety outcomes for
youth, Chu and Harrison (2007) found that CBT had statistically
significant and large-sized effects on behavioral processes and
moderate effects on physiological and cognitive processes and
coping. However, the vast majority of the studies included in this
meta-analysis did not report a formal test of mediation. Finally,
two reviews summarized studies testing mediators in youth.
The first review was conducted by Weersing and Weisz (2002)
and identified one study where changes in arousal were related
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to anxiety measures, although this study did not conduct
analyses to test for mediated effects. The second review, by
Silverman et al. (2008), identified two studies on cognitive
mediators in youth psychotherapy for anxiety. They concluded
that self-talk and positive self-statements mediated change in
anxiety symptoms; however, these mediators were not assessed
during treatment.
Since both the presentation of psychological symptoms and
psychological treatments for adolescents and young adults are
slightly different from those for adults, the potential mediators
and mechanisms of change may also differ between adults and
youth. To our knowledge there are no systematic reviews of
mediators of all branches or types of psychological treatments
for anxiety and/or depression in adolescents and young adults.
The aims of this systematic review will be: (1) to identify
which mediators and theories of change have been studied
in psychological treatments for anxiety and depression in
adolescents and young adults, (2) to identify those mediators
and theories of change with the strongest empirical support
for the treatment of anxiety and depression in adolescents and
young adults, and (3) to critically evaluate the methodological
characteristics and quality of the current research data available
on mediators in psychological treatments for anxiety and
depression in adolescents and young adults.
This systematic review is carried out as part of the “European
Network of Individualized Psychotherapy Treatment of Young
People with Mental Disorders” (TREATme)1, funded by the
European Cooperation in Science and Technology (COST).
TREATme will review the academic research relating to
mediators in young people receiving psychological treatments.
METHODS
Reporting and Protocol Registration
This protocol is following the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses Protocols guidelines
(PRISMA-P) (Moher et al., 2015) and will adhere to the PRISMA
2020 statement (Page et al., 2021). The study protocol was
previously registered in the International Prospective Register of
Systematic Reviews (registration number: CRD42021234641).
Information Sources and Search
Strategy
Systematic literature searches for relevant studies have
been conducted in the following databases: PsycINFO
and PubMed (Medline) from inception to February 23rd,
2020. The searches will be updated just before the final
results are analyzed to retrieve the most recent studies for
inclusion. We will perform hand-searching of the reference
list of included studies and relevant systematic reviews on
the topic. We will contact experts in the field to retrieve
additional studies. The searches include a broad range of
terms and keywords related to mediators, young people
and psychological treatments. The specific search strategy
1www.treat-me.eu
used in PubMed (Medline) and PsycINFO is provided in
Supplementary Material 1.
Eligibility Criteria
Studies will be included in this systematic review based on the
following criteria:
Participants
We will include studies involving adolescents and young
adults aged between 10 and 30 years old, with a diagnosis of
depression and/or anxiety through standardized instruments
(e.g., Structured Clinical Interview for DSM Disorders), through
validated self-reports with standard cut-off points (e.g., Beck
Depression Inventory-II; Beck Anxiety Inventory-II), or
diagnosis by a mental health specialist.
Intervention
Eligible interventions will aim at treating or ameliorating
depression and/or anxiety and will include all branches
or types of interventions: psychodynamic, integrative,
systemic, cognitive-based or cognitive-behavioral,
interpersonal, humanistic, psychoeducation, and third-
wave approaches. Face-to-face interventions (individual
and group), internet-based interventions (guided,
unguided, psychoeducational websites) or a combination
between them will be included. Interventions that are
pharmacological or physical (e.g., exercise) will not be
included. In addition, those studies that included adjunct
pharmacotherapy or physical to a psychological treatment will
also be excluded.
Comparator
Usual care, waiting list, attention control, or other type of
comparators will be included.
Outcome
Studies will be included if they examine the psychological
mediators and statistical analysis of mediation of psychotherapy
outcome (Baron and Kenny, 1986 or more advanced methods).
We will include outcome measures assessing diagnosis status and
symptom severity for symptoms of anxiety and depression.
Study Design
Randomized controlled trials and trials (quasi-experimental)
designs will be included. Other types of designs will be excluded.
Setting, Language, and Publication Date
Studies from any setting, written in English and published from
inception onwards, will be eligible.
Selection Procedure
A group of 20 experienced researchers (from now on reviewers),
divided into 10 pairs, will conduct the study selection. Before
selecting studies, the group of reviewers will develop and agree
to adhere to a homogeneous screening and rating procedure.
The 10 pairs of reviewers will independently assess the eligibility
of studies retrieved in two phases. After duplicate studies
are eliminated in the first phase, titles and abstracts of all
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studies retrieved will be screened. Those studies that will not
meet the inclusion criteria outlined above will be excluded.
In the second phase, each pair of reviewers will evaluate
the full text of these potentially eligible studies to check if
they meet the inclusion criteria. Any discrepancies in selected
studies will be discussed in pairs, and a third reviewer will
be consulted if a consensus cannot be reached. To guarantee
the study selection process, independent reviewers will perform
an additional quality control check by assessing the eligibility
of every fifth excluded study. Discrepancies at this stage will
be resolved through discussion with the original reviewer pair.
A PRISMA flow chart showing the details of studies included
and excluded at each phase of the study selection process
will be provided.
Data Extraction
Data extraction will also be performed independently by pairs
of reviewers. Discrepancies between the reviewers will be
resolved by discussion or with a third reviewer where necessary.
A data extraction sheet will be used, and the following study
characteristics will be extracted for each included study: study
setting; study population, participant demographics, and baseline
characteristics; details of the treatment and control conditions;
study methodology; outcomes and times of measurement;
assessed mediators; type of mediation analysis and information
for the assessment of the risk of bias. We will use Microsoft Excel
(2013) to manage the data extraction process.
Data Synthesis
The characteristics of the included studies will be presented
in different tables. We will synthesize the results from the
included studies and draw conclusions based on the body of
evidence using standard methods for narrative syntheses, as
described by Popay et al. (2006). The narrative synthesis will be
focused on the categories of mediators that have been tested,
types of psychological treatments that have been investigated,
type of population (clinical-subclinical), mental disorders or
psychological symptoms (depression-anxiety) that have been
treated and age range that has been considered (adolescents-
young adults). Included studies can be grouped by disorder
(depression-anxiety), by population (clinical-subclinical), by
treatment type (e.g., cognitive behavioral therapy, interpersonal
therapy) and/or age range. It will be discussed if age-, disorder-
or treatment-specific mediators can be identified.
Critical Appraisal
To evaluate the quality of the mediation studies, we will use the
most relevant criteria of requirements according to Kazdin and
Nock (2003); Kazdin (2007), and Lemmens et al. (2016). We
will evaluate specificity (the mediator is specific for a particular
type of therapy), temporal relation (the mediator should precede
the outcome in time) and experimental manipulation (direct
manipulation of the mediator through an experiment). We will
use a strong association requirement to ascertain whether there
was a statistical association between variables (Kazdin, 2007;
Kazdin and Nock, 2003). According to Lemmens et al. (2016),
we will also evaluate whether multiple mediators have been
examined. Two reviewers will independently assess the quality
of the mediation studies, and any discrepancies will be discussed
until consensus is reached.
Risk of Bias in Individual Studies
The latest version of the Mixed Method Appraisal Tool (MMAT,
Hong et al., 2018) will be used to assess the quality of
the studies included. The MMAT is designed to evaluate
mixed studies, including five categories of studies: qualitative
research, randomized controlled trials, non-randomized studies,
quantitative descriptive studies, and mixed methods studies. The
tool comprises two screening questions, and five criteria for each
type of study scored on a categorical scale as either “yes,” “no,”
or “cannot tell.” The initial two screening questions indicate
whether a further methodological quality appraisal is feasible or
appropriate. If responses to both questions are either “no” or
“cannot tell,” they will be excluded from further evaluation. To
obtain an overall quality score for each study, items score as
“yes” would be summed. The overall score ranges from 0 to 5
points (“0” the lowest quality score and “5” the highest quality
score). The two reviewers will independently judge the quality
of the included studies, and any discrepancies will be resolved
through discussion.
Amendments to the Protocol
In case of any amendments made to this protocol when
conducting the systematic review, we will document all changes
in PROSPERO and the final publication.
DISCUSSION
This protocol lays out a plan for a systematic review to
provide more knowledge about the mediators of various
psychological treatments for adolescents and young adults
suffering from depression and/or anxiety. Identifying likely or
promising treatment mediators advances our understanding of
how treatments for depression and anxiety affect adolescents and
young adults. This can help develop more effective treatments
and prevent treatment failure or adverse events. In addition,
results might assist in the verification and refinement of how
treatments for depression and anxiety might work in adolescents
and young adults. Based on the results, we will have information
on the similarity or difference in mediators of psychological
treatments in adolescents compared to young adults.
One of the main strengths of this study is the inclusion
of a large multidisciplinary group of international researchers
with extensive experience in this area who have worked for
3 years on this project. Moreover, for the correct development
of this protocol, the group has consulted international experts
in the field. This systematic review will cover all psychological
treatments and focus on the two most prevalent mental health
conditions in adolescents and young adults. In addition, we will
rigorously follow the PRISMA guidelines. According to the open
science initiative recommendations, the data set will be made
available to other research groups.
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However, there could be several limitations of this study
that should be considered. The substantial heterogeneity in
terms of design, therapies and mediation analyses of included
studies might cause one crucial limitation, which likely limits
the possibility to estimate aggregated effect sizes for the
identified mediators. According to Higgins and Green (2011),
one of the circumstances where it may not be possible to
undertake a statistical synthesis is when studies are too diverse
since the results may be obscured. Although both RCTs and
quasi-experimental designs are valid to demonstrate causal
relationship between psychological treatments and outcomes,
quasi-experimental designs have lower quality with regard to
the internal validity than RCTs. According to previous studies
on psychological mediators (Lemmens et al., 2016; Weersing
et al., 2017; Moreno-Peral et al., 2020; Ng et al., 2020), we
expect low compliance with the methodological requirements
to establish as a mediator. Furthermore, only studies written
in English will be included, so studies with our inclusion
criteria written in other languages may not be considered.
Although we plan to search for studies in two different databases,
contact experts, review the reference list of included studies
and relevant systematic reviews on this topic, missing some
studies is inevitable.
In summary, the evidence from this systematic review
will inform treatment development by highlighting the
mediators responsible for therapeutic change and will
extend the evidence based on the efficacy of psychological
treatments for depression and anxiety in adolescents
and young adults.
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